Santevia, National Vitamin Company Win DSN/ECRM Buyers’ Choice Awards
Santevia Water Systems won the Drug Store News/ECRM Buyers’ Choice Award for its Santevia Power Stick portable water filtration technology during ECRM’s recent Vitamin, Weight Management & Sports Nutrition EPPS. National Vitamin Company was a finalist with its Veterans Multi Vitamin Pack.
The two companies were selected from dozens of entries in the award program, samples of which were displayed in the ECRM hospitality area during the EPPS meetings. Buyers cast their votes based on product innovation and packaging.
Founded in 2007 by Yvonne and David Anderson, British Columbia, Canada-based Santevia Water Systems’ line of filtration products are designed to improve the health benefits of water.
Its Santevia Power Stick portable water filtration system is designed for healthy water on the go, with the company touting its ability to reduce chlorine by 99.9%. It also adjusts water’s pH to mildly alkaline by reintroducing minerals that promote ionization and oxygenation, which helps the body maintain its active equilibrium, according to the company. It can be added to any water bottle, then shaken for 30 seconds. Each power stick makes 300 bottles of clean, mineralized, alkaline water. Using the product also prevents thousands of single-use plastic water bottles from entering the landfill each year.
Family-owned and operated, Casa Grande, Ariz.-based National Vitamin Company manufactures more than 600 general and custom products under such various brands as Nature’s Blend, as well as various private-label programs.
The company originally developed the Veterans Multi Vitamin Pack as a cause promotion to give back to events sponsored by the Veterans Administration and has since expanded its reach into sponsorships of veterans in such additional events as the Paralympic Games. Veterans featured in its vitamin packs are participants in VA National Rehabilitation Games or sports clinics.
Nutritional Delivery Systems launches CurcuminPro product line
Nutritional Delivery Systems earlier this week showed off its BioSoluble line of curcumin-based meal-replacement shakes, capsules and candies from its CurcuminPro product line, which uses a tasteless curcumin-protein conjugate called CPro, at January’s ECRM VMS EPPS event.
“ECRM was a great chance to get our CurcuminPro line in front of major players in the retail industry and show them a revolutionary new way to get curcumin into peoples’ diets,” Ron Gourley, CEO Nutritional Delivery Systems said. “We loved discussing the unique CPro conjugate and what it means for the future of health supplements. Our extended research dives in-depth into the benefits of vegetables, fiber, protein, essential amino acids, including BCAAs, antioxidants, vitamins, minerals and many other components of our diverse product line.”
CurcuminPro uses CPro in its curcumin-enhanced products, which include capsules, chewables, powdered drink mixes, bottled drinks, chocolate and jelly bean confections, and even pet food toppers. The active ingredient, CPro, has no taste or odor and is 36 times more soluble than standard curcumin. Curcumin-enriched diets are believed to have all sorts of health benefits, including helping to improve skin, immune system, digestive, skeletal and joint health and liver function.
ECRM’s Vitamin, Weight Management and Sports Nutrition Efficient Program Planning Sessions is a trade show where vitamin, diet and nutrition companies are able to network with major retail buyers in private sessions and show off their products.
Report: J&J pulls out of the race for Pfizer’s consumer business
Johnson & Johnson is officially out of the running for Pfizer’s Consumer business, Reuters reported Thursday.
“While we would normally not comment on market speculation or rumors, in this instance we refute assertions that we are in negotiation for Pfizer’s consumer business,” J&J’s vice president of media relations Ernie Knewitz told Reuters.
That leaves GSK Consumer and RB in the running for the business. Pfizer is accepting bids on its business through Feb. 1 and is hoping to clear at least $20 billion in the sale, Reuters reported.
Drug Store News provided a look at who may or may not be interested in a Pfizer consumer business in Ocotober.
Pfizer fields several leading OTC brands across many of the more significant non-prescription categories. The company boasted almost $600 million in annual sales across U.S. total multi-outlets through its internal analgesic franchise (Advil and Advil PM) for the 52 weeks ended June 11, 2017, according to IRI. The proton pump inhibitor Nexium 24HR generated another $300 million and its vitamin lineup, featuring Centrum, pulled in more than $280 million.
According to Kline Group, based on 2016 sales Bayer holds an 8.2% market share of the overall OTC busines, with Johnson & Johnson following at 7.5% and GlaxoSmithKline Consumer Healthcare at 6.5%. Pfizer stands at No. 4 on that list with a 6.2% market share, followed by Procter & Gamble (4.5%), Sanofi (4.4%), Reckitt Benckiser (4%), Prestige Brands (1.9%), Church & Dwight (1.2%) and Carlyle Group (1%).
The marketshare figures are attributable to Kline & Company’s latest “Nonprescription Drugs USA” study.
For the full Reuters story, click here.